Senior Manager, Cost Accounting

The role

The Senior Manager, Cost Accounting oversees cost accounting including cost of goods sold, bill of materials and inventory costing. This person provides reporting and analysis to the corporate finance and accounting team to support strategic and operational planning.

What you will do

• Oversee monthly/quarterly close process for general ledger accounts.
• Prepare and analyze financial statements for the Company.
• Ownership of overhead cost pool accumulation and allocation/absorption.
• Ensure and coordinate timely monthly and quarterly cost accounting close activities for inventory and cost of sales.
• Oversee quarterly and year-end physical inventory process with the operations team.
• Coordinate calculation and recording of appropriate inventory reserves.
• Collaborate with Internal Audit for Sarbanes-Oxley compliance for inventory and cost of sales.
• Support the forecast and budget process with inputs related to product volumes, purchases, overhead, and costs.
• Analyze manufacturing organization spending and support FP&A preparation for financial review meetings.
• Directly supervise and develop a team of two Cost Accounting professionals.

Required qualifications

• BA or BS in Accounting
• 9+ years of progressive experience in accounting with cost accounting focus
• Must have worked in Life Sciences, biotech or pharmaceutical industry.
• Strong understanding of GAAP and financial accounting
• Experience operating within a Sarbanes-Oxley control environment.
• Strong forecasting and analytical skills
• Advanced Microsoft Excel, Word and PowerPoint skills
• Excellent interpersonal and communication skills
• Ability to build partnerships across functions.
• Detail oriented
• Proactive problem solver
• Strong work ethic and ability to independently prioritize workload

Nice to have

• CPA
• Big 4 experience
• NetSuite experience

About the company

Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. The company operates as an end-to-end cell therapy company with centralized U.S.-based manufacturing.